Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Brazil

 

Rede D’Or backs down on Alliar

Brazilian hospital group Rede D'Or has pulled back on its attempt to takeover imaging group Alliar after it became clear it could not take control. However, large lab group Fleury has now also thrown its hat into the ring for a stake.

Rede D’Or bids for Alliar

Brazil's largest hospital group Rede D'Or has launched a takeover bid for one of the country's largest diagnostic groups Alliar. 

Rede D’Or to build new hospitals with $340m follow-on

Brazil's largest hospital group Rede D'Or has raised $340m in new shares with a follow-on that includes Carlyle selling down its stake. It says it will use the proceeds of the primary offering to build and acquire new assets.

Fleury acquires Sao Paulo orthopaedics group

Fleury Group, the second largest diagnostics group in Brazil, has signed an agreement to buy a two-thirds stake in orthopaedic and rehabilitation specialist Vita Ortopedia Servicos Especializados. This continues its march towards becoming an integrated platform.

$20bn merger could transform Brazilian healthcare market

A $20bn merger between two giants of Brazilian healthcare, listed HMOs Hapvida Participacoes e Investimentos SA and Notre Dame Intermedica Participacoes SA (GNDI), will create one of the world’s biggest companies providing verticalized health-care solutions. HBI looks at the deal in detail, and talks to a Brazil-based operator to find out more.

Atrys CFO on recent M&A and pan-European radiotherapy plans

Spain-listed diagnostics and radiotherapy group Atrys Health's CFO talks HBI through the strategic rationale of its spate of recent acquisitions including a €550m merger with another listed group, after we questioned the diversity of deal-making it is pursuing. He says it is looking at acquiring radiotherapy centres in Europe outside Iberia. 

Rede d’Or’s payors losing market cap

Analysts covering Brazil's largest private hospital Rede d'Or have projected a 25% rise share price after its $2.2bn IPO last month. However, the sustainability of its fee-for-service business model in the long-term has been questioned by some. Its insurers are slowly losing market cap to integrated players.

UHCG faces tough call in Brazil

Amy Shaw, the incoming CEO of UnitedHealthcare Global (UHCG), the world's largest owner of for-profit hospitals in emerging markets, faces tough choices. UHCG, the international arm of US insurer UnitedHealth, has a colossal headache in Brazil, by far its largest market. For instance, reports suggest UHCG may have to pay R$1bn to shift its personal policy portfolio in a deal which has already been sweetened by the addition of several hospitals. There is speculation that, like Cigna in the 1990s, which wrote off some US$500m on medical plan Golden Cross, that UnitedHealth may decide to exit Brazil completely. A full pull-out looks unlikely, but the full year 2020 results to be announced on Wednesday, January 20 may well see big write-offs. 

Find Us